nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—prostate cancer	0.333	1	CbGaD
Flucloxacillin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0973	0.207	CbGbCtD
Flucloxacillin—CYP3A4—Bicalutamide—prostate cancer	0.0511	0.109	CbGbCtD
Flucloxacillin—CYP3A4—Estramustine—prostate cancer	0.0475	0.101	CbGbCtD
Flucloxacillin—CYP3A4—Abiraterone—prostate cancer	0.0424	0.09	CbGbCtD
Flucloxacillin—CYP3A4—Flutamide—prostate cancer	0.0424	0.09	CbGbCtD
Flucloxacillin—CYP3A4—Cabazitaxel—prostate cancer	0.0313	0.0666	CbGbCtD
Flucloxacillin—CYP3A4—Estrone—prostate cancer	0.0306	0.0651	CbGbCtD
Flucloxacillin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0273	0.058	CbGbCtD
Flucloxacillin—CYP3A4—Conjugated Estrogens—prostate cancer	0.02	0.0426	CbGbCtD
Flucloxacillin—CYP3A4—Mitoxantrone—prostate cancer	0.0182	0.0387	CbGbCtD
Flucloxacillin—CYP3A4—Estradiol—prostate cancer	0.0176	0.0374	CbGbCtD
Flucloxacillin—CYP3A4—Prednisone—prostate cancer	0.0151	0.0321	CbGbCtD
Flucloxacillin—CYP3A4—Etoposide—prostate cancer	0.0115	0.0244	CbGbCtD
Flucloxacillin—CYP3A4—Docetaxel—prostate cancer	0.0105	0.0223	CbGbCtD
Flucloxacillin—CYP3A4—Doxorubicin—prostate cancer	0.00783	0.0166	CbGbCtD
Flucloxacillin—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—prostate cancer	0.000272	0.0101	CbGpPWpGaD
Flucloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—prostate cancer	0.000268	0.00995	CbGpPWpGaD
Flucloxacillin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—prostate cancer	0.000259	0.00963	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—SULT2A1—prostate cancer	0.000251	0.00931	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	0.000245	0.00908	CbGpPWpGaD
Flucloxacillin—CYP3A4—Xenobiotics—CYP2C19—prostate cancer	0.000232	0.00862	CbGpPWpGaD
Flucloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—prostate cancer	0.000228	0.00846	CbGpPWpGaD
Flucloxacillin—CYP3A4—Xenobiotics—CYP2A6—prostate cancer	0.000224	0.00832	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP2C19—prostate cancer	0.000224	0.00829	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A43—prostate cancer	0.000222	0.00823	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP3A43—prostate cancer	0.000219	0.00812	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTK1—prostate cancer	0.000216	0.00803	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTCD—prostate cancer	0.000216	0.00803	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP2A6—prostate cancer	0.000216	0.008	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP7B1—prostate cancer	0.000213	0.00791	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	0.000211	0.00781	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	0.000208	0.00772	CbGpPWpGaD
Flucloxacillin—CYP3A4—Estrogen metabolism—NQO1—prostate cancer	0.000205	0.00761	CbGpPWpGaD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	0.000198	0.00735	CbGpPWpGaD
Flucloxacillin—CYP3A4—Estrogen metabolism—CYP1B1—prostate cancer	0.000197	0.0073	CbGpPWpGaD
Flucloxacillin—CYP3A4—Xenobiotics—CYP2E1—prostate cancer	0.000191	0.00707	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP2E1—prostate cancer	0.000183	0.0068	CbGpPWpGaD
Flucloxacillin—CYP3A4—Aflatoxin activation and detoxification—GGT1—prostate cancer	0.000182	0.00677	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A43—prostate cancer	0.00018	0.00667	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	0.000179	0.00664	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP1B1—prostate cancer	0.000174	0.00645	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7B1—prostate cancer	0.000172	0.0064	CbGpPWpGaD
Flucloxacillin—CYP3A4—Estrogen metabolism—COMT—prostate cancer	0.000172	0.00638	CbGpPWpGaD
Flucloxacillin—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—prostate cancer	0.000171	0.00634	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP7B1—prostate cancer	0.00017	0.00631	CbGpPWpGaD
Flucloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	0.000169	0.00628	CbGpPWpGaD
Flucloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—prostate cancer	0.000164	0.00608	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	0.00016	0.00592	CbGpPWpGaD
Flucloxacillin—CYP3A4—Estrogen metabolism—GSTM1—prostate cancer	0.000157	0.00583	CbGpPWpGaD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	0.000154	0.00571	CbGpPWpGaD
Flucloxacillin—CYP3A4—Estrogen metabolism—CYP1A1—prostate cancer	0.000149	0.00553	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—prostate cancer	0.000148	0.00549	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—prostate cancer	0.000146	0.00542	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP2C18—prostate cancer	0.000144	0.00535	CbGpPWpGaD
Flucloxacillin—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000143	0.000843	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—prostate cancer	0.000143	0.000843	CcSEcCtD
Flucloxacillin—CYP3A4—Irinotecan Pathway—APC—prostate cancer	0.000143	0.0053	CbGpPWpGaD
Flucloxacillin—Dizziness—Goserelin—prostate cancer	0.000141	0.000829	CcSEcCtD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	0.00014	0.00521	CbGpPWpGaD
Flucloxacillin—Erythema multiforme—Capecitabine—prostate cancer	0.00014	0.000824	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP7B1—prostate cancer	0.00014	0.00519	CbGpPWpGaD
Flucloxacillin—Dizziness—Conjugated Estrogens—prostate cancer	0.000139	0.000821	CcSEcCtD
Flucloxacillin—Feeling abnormal—Estradiol—prostate cancer	0.000139	0.000819	CcSEcCtD
Flucloxacillin—Convulsion—Etoposide—prostate cancer	0.000139	0.000817	CcSEcCtD
Flucloxacillin—Dyspepsia—Mitoxantrone—prostate cancer	0.000138	0.000815	CcSEcCtD
Flucloxacillin—Immune system disorder—Docetaxel—prostate cancer	0.000138	0.000813	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Estradiol—prostate cancer	0.000138	0.000812	CcSEcCtD
Flucloxacillin—CYP3A4—Xenobiotics—CYP1A1—prostate cancer	0.000137	0.00508	CbGpPWpGaD
Flucloxacillin—Decreased appetite—Mitoxantrone—prostate cancer	0.000136	0.000805	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000135	0.000798	CcSEcCtD
Flucloxacillin—Vomiting—Goserelin—prostate cancer	0.000135	0.000797	CcSEcCtD
Flucloxacillin—Discomfort—Etoposide—prostate cancer	0.000135	0.000793	CcSEcCtD
Flucloxacillin—Constipation—Mitoxantrone—prostate cancer	0.000134	0.000792	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000134	0.000791	CcSEcCtD
Flucloxacillin—Rash—Goserelin—prostate cancer	0.000134	0.00079	CcSEcCtD
Flucloxacillin—Dermatitis—Goserelin—prostate cancer	0.000134	0.000789	CcSEcCtD
Flucloxacillin—Vomiting—Conjugated Estrogens—prostate cancer	0.000134	0.000789	CcSEcCtD
Flucloxacillin—Urticaria—Estradiol—prostate cancer	0.000134	0.000789	CcSEcCtD
Flucloxacillin—Immune system disorder—Capecitabine—prostate cancer	0.000134	0.000788	CcSEcCtD
Flucloxacillin—Body temperature increased—Estradiol—prostate cancer	0.000133	0.000785	CcSEcCtD
Flucloxacillin—Abdominal pain—Estradiol—prostate cancer	0.000133	0.000785	CcSEcCtD
Flucloxacillin—Headache—Goserelin—prostate cancer	0.000133	0.000785	CcSEcCtD
Flucloxacillin—Rash—Conjugated Estrogens—prostate cancer	0.000133	0.000783	CcSEcCtD
Flucloxacillin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000133	0.000782	CcSEcCtD
Flucloxacillin—Headache—Conjugated Estrogens—prostate cancer	0.000132	0.000778	CcSEcCtD
Flucloxacillin—CYP3A4—Tamoxifen metabolism—CYP1A1—prostate cancer	0.000132	0.00489	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—prostate cancer	0.000131	0.00485	CbGpPWpGaD
Flucloxacillin—Anaphylactic shock—Etoposide—prostate cancer	0.000131	0.00077	CcSEcCtD
Flucloxacillin—Dysgeusia—Docetaxel—prostate cancer	0.00013	0.000768	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Prednisone—prostate cancer	0.000129	0.000763	CcSEcCtD
Flucloxacillin—Feeling abnormal—Mitoxantrone—prostate cancer	0.000129	0.000763	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000128	0.000757	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Etoposide—prostate cancer	0.000128	0.000754	CcSEcCtD
Flucloxacillin—Eosinophilia—Epirubicin—prostate cancer	0.000127	0.000751	CcSEcCtD
Flucloxacillin—Skin disorder—Etoposide—prostate cancer	0.000127	0.000748	CcSEcCtD
Flucloxacillin—Nausea—Goserelin—prostate cancer	0.000126	0.000744	CcSEcCtD
Flucloxacillin—Dysgeusia—Capecitabine—prostate cancer	0.000126	0.000743	CcSEcCtD
Flucloxacillin—Nausea—Conjugated Estrogens—prostate cancer	0.000125	0.000737	CcSEcCtD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	0.000125	0.00463	CbGpPWpGaD
Flucloxacillin—Urticaria—Mitoxantrone—prostate cancer	0.000125	0.000735	CcSEcCtD
Flucloxacillin—Hypersensitivity—Estradiol—prostate cancer	0.000124	0.000732	CcSEcCtD
Flucloxacillin—Body temperature increased—Mitoxantrone—prostate cancer	0.000124	0.000732	CcSEcCtD
Flucloxacillin—Abdominal pain—Mitoxantrone—prostate cancer	0.000124	0.000732	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000124	0.000732	CcSEcCtD
Flucloxacillin—Anaemia—Docetaxel—prostate cancer	0.000123	0.000725	CcSEcCtD
Flucloxacillin—Neutropenia—Epirubicin—prostate cancer	0.00012	0.00071	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—prostate cancer	0.00012	0.00445	CbGpPWpGaD
Flucloxacillin—Ill-defined disorder—Capecitabine—prostate cancer	0.000119	0.000704	CcSEcCtD
Flucloxacillin—Leukopenia—Docetaxel—prostate cancer	0.000119	0.000702	CcSEcCtD
Flucloxacillin—Anaemia—Capecitabine—prostate cancer	0.000119	0.000702	CcSEcCtD
Flucloxacillin—Immune system disorder—Prednisone—prostate cancer	0.000119	0.000702	CcSEcCtD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.000118	0.00439	CbGpPWpGaD
Flucloxacillin—Eosinophilia—Doxorubicin—prostate cancer	0.000118	0.000695	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	0.000116	0.00432	CbGpPWpGaD
Flucloxacillin—Malaise—Capecitabine—prostate cancer	0.000116	0.000684	CcSEcCtD
Flucloxacillin—Hypersensitivity—Mitoxantrone—prostate cancer	0.000116	0.000682	CcSEcCtD
Flucloxacillin—Diarrhoea—Estradiol—prostate cancer	0.000115	0.00068	CcSEcCtD
Flucloxacillin—Leukopenia—Capecitabine—prostate cancer	0.000115	0.000679	CcSEcCtD
Flucloxacillin—Convulsion—Docetaxel—prostate cancer	0.000115	0.000679	CcSEcCtD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.000115	0.00427	CbGpPWpGaD
Flucloxacillin—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000114	0.000671	CcSEcCtD
Flucloxacillin—Decreased appetite—Etoposide—prostate cancer	0.000114	0.000669	CcSEcCtD
Flucloxacillin—Arthralgia—Docetaxel—prostate cancer	0.000113	0.000667	CcSEcCtD
Flucloxacillin—Myalgia—Docetaxel—prostate cancer	0.000113	0.000667	CcSEcCtD
Flucloxacillin—Renal failure—Epirubicin—prostate cancer	0.000113	0.000665	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Etoposide—prostate cancer	0.000113	0.000665	CcSEcCtD
Flucloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000113	0.00418	CbGpPWpGaD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000112	0.000663	CcSEcCtD
Flucloxacillin—Jaundice—Epirubicin—prostate cancer	0.000112	0.00066	CcSEcCtD
Flucloxacillin—Constipation—Etoposide—prostate cancer	0.000112	0.000658	CcSEcCtD
Flucloxacillin—Dizziness—Estradiol—prostate cancer	0.000111	0.000657	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—prostate cancer	0.000111	0.000657	CcSEcCtD
Flucloxacillin—Myalgia—Capecitabine—prostate cancer	0.00011	0.000646	CcSEcCtD
Flucloxacillin—Arthralgia—Capecitabine—prostate cancer	0.00011	0.000646	CcSEcCtD
Flucloxacillin—Haematuria—Epirubicin—prostate cancer	0.000109	0.000645	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000109	0.000642	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Epirubicin—prostate cancer	0.000109	0.00064	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Docetaxel—prostate cancer	0.000109	0.00064	CcSEcCtD
Flucloxacillin—Discomfort—Capecitabine—prostate cancer	0.000108	0.000638	CcSEcCtD
Flucloxacillin—Feeling abnormal—Etoposide—prostate cancer	0.000108	0.000634	CcSEcCtD
Flucloxacillin—Diarrhoea—Mitoxantrone—prostate cancer	0.000107	0.000633	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	0.000107	0.00397	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	0.000107	0.00397	CbGpPWpGaD
Flucloxacillin—Vomiting—Estradiol—prostate cancer	0.000107	0.000632	CcSEcCtD
Flucloxacillin—Agranulocytosis—Epirubicin—prostate cancer	0.000107	0.000631	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Etoposide—prostate cancer	0.000107	0.00063	CcSEcCtD
Flucloxacillin—Nervous system disorder—Docetaxel—prostate cancer	0.000106	0.000627	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Prednisone—prostate cancer	0.000106	0.000627	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Docetaxel—prostate cancer	0.000106	0.000626	CcSEcCtD
Flucloxacillin—Rash—Estradiol—prostate cancer	0.000106	0.000626	CcSEcCtD
Flucloxacillin—Dermatitis—Estradiol—prostate cancer	0.000106	0.000626	CcSEcCtD
Flucloxacillin—Anaemia—Prednisone—prostate cancer	0.000106	0.000625	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	0.000106	0.00393	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	0.000106	0.00392	CbGpPWpGaD
Flucloxacillin—Headache—Estradiol—prostate cancer	0.000106	0.000622	CcSEcCtD
Flucloxacillin—Skin disorder—Docetaxel—prostate cancer	0.000105	0.000621	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000105	0.000621	CcSEcCtD
Flucloxacillin—Angioedema—Prednisone—prostate cancer	0.000105	0.000618	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—prostate cancer	0.000104	0.000615	CcSEcCtD
Flucloxacillin—Urticaria—Etoposide—prostate cancer	0.000104	0.000612	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—prostate cancer	0.000103	0.00061	CcSEcCtD
Flucloxacillin—Malaise—Prednisone—prostate cancer	0.000103	0.00061	CcSEcCtD
Flucloxacillin—Abdominal pain—Etoposide—prostate cancer	0.000103	0.000609	CcSEcCtD
Flucloxacillin—Body temperature increased—Etoposide—prostate cancer	0.000103	0.000609	CcSEcCtD
Flucloxacillin—Nervous system disorder—Capecitabine—prostate cancer	0.000103	0.000608	CcSEcCtD
Flucloxacillin—Hepatitis—Epirubicin—prostate cancer	0.000103	0.000607	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Capecitabine—prostate cancer	0.000103	0.000607	CcSEcCtD
Flucloxacillin—Skin disorder—Capecitabine—prostate cancer	0.000102	0.000602	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Epirubicin—prostate cancer	0.000102	0.0006	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—prostate cancer	0.000101	0.000597	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Epirubicin—prostate cancer	0.000101	0.000597	CcSEcCtD
Flucloxacillin—Urethral disorder—Epirubicin—prostate cancer	0.000101	0.000595	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—GSTM3—prostate cancer	0.000101	0.00374	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	0.000101	0.00374	CbGpPWpGaD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—prostate cancer	0.0001	0.000592	CcSEcCtD
Flucloxacillin—Nausea—Estradiol—prostate cancer	0.0001	0.00059	CcSEcCtD
Flucloxacillin—Vomiting—Mitoxantrone—prostate cancer	9.98e-05	0.000588	CcSEcCtD
Flucloxacillin—Convulsion—Prednisone—prostate cancer	9.93e-05	0.000586	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	9.93e-05	0.00369	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	9.93e-05	0.00369	CbGpPWpGaD
Flucloxacillin—Agranulocytosis—Doxorubicin—prostate cancer	9.91e-05	0.000584	CcSEcCtD
Flucloxacillin—Rash—Mitoxantrone—prostate cancer	9.9e-05	0.000584	CcSEcCtD
Flucloxacillin—Dermatitis—Mitoxantrone—prostate cancer	9.89e-05	0.000583	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.89e-05	0.000583	CcSEcCtD
Flucloxacillin—Headache—Mitoxantrone—prostate cancer	9.83e-05	0.00058	CcSEcCtD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	9.79e-05	0.00363	CbGpPWpGaD
Flucloxacillin—Myalgia—Prednisone—prostate cancer	9.76e-05	0.000576	CcSEcCtD
Flucloxacillin—Arthralgia—Prednisone—prostate cancer	9.76e-05	0.000576	CcSEcCtD
Flucloxacillin—Erythema multiforme—Epirubicin—prostate cancer	9.74e-05	0.000574	CcSEcCtD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	9.72e-05	0.00361	CbGpPWpGaD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	9.69e-05	0.000572	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	9.65e-05	0.00358	CbGpPWpGaD
Flucloxacillin—Discomfort—Prednisone—prostate cancer	9.64e-05	0.000569	CcSEcCtD
Flucloxacillin—Hypersensitivity—Etoposide—prostate cancer	9.62e-05	0.000567	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.57e-05	0.000564	CcSEcCtD
Flucloxacillin—Dyspepsia—Docetaxel—prostate cancer	9.55e-05	0.000563	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	9.55e-05	0.00354	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—NAT1—prostate cancer	9.55e-05	0.00354	CbGpPWpGaD
Flucloxacillin—Hepatitis—Doxorubicin—prostate cancer	9.53e-05	0.000562	CcSEcCtD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	9.52e-05	0.00353	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	9.44e-05	0.0035	CbGpPWpGaD
Flucloxacillin—Decreased appetite—Docetaxel—prostate cancer	9.43e-05	0.000556	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	9.42e-05	0.00349	CbGpPWpGaD
Flucloxacillin—Urinary tract disorder—Doxorubicin—prostate cancer	9.41e-05	0.000555	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Docetaxel—prostate cancer	9.37e-05	0.000552	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—prostate cancer	9.37e-05	0.000552	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Prednisone—prostate cancer	9.36e-05	0.000552	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—prostate cancer	9.34e-05	0.000551	CcSEcCtD
Flucloxacillin—Nausea—Mitoxantrone—prostate cancer	9.32e-05	0.00055	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	9.31e-05	0.00346	CbGpPWpGaD
Flucloxacillin—Immune system disorder—Epirubicin—prostate cancer	9.3e-05	0.000549	CcSEcCtD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	9.28e-05	0.00344	CbGpPWpGaD
Flucloxacillin—Constipation—Docetaxel—prostate cancer	9.28e-05	0.000547	CcSEcCtD
Flucloxacillin—Dyspepsia—Capecitabine—prostate cancer	9.25e-05	0.000545	CcSEcCtD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	9.19e-05	0.00341	CbGpPWpGaD
Flucloxacillin—Nervous system disorder—Prednisone—prostate cancer	9.18e-05	0.000541	CcSEcCtD
Flucloxacillin—Decreased appetite—Capecitabine—prostate cancer	9.13e-05	0.000539	CcSEcCtD
Flucloxacillin—Skin disorder—Prednisone—prostate cancer	9.09e-05	0.000536	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Capecitabine—prostate cancer	9.07e-05	0.000535	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—prostate cancer	9.01e-05	0.000531	CcSEcCtD
Flucloxacillin—Constipation—Capecitabine—prostate cancer	8.98e-05	0.00053	CcSEcCtD
Flucloxacillin—Feeling abnormal—Docetaxel—prostate cancer	8.94e-05	0.000527	CcSEcCtD
Flucloxacillin—Diarrhoea—Etoposide—prostate cancer	8.93e-05	0.000527	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	8.92e-05	0.00331	CbGpPWpGaD
Flucloxacillin—Gastrointestinal pain—Docetaxel—prostate cancer	8.87e-05	0.000523	CcSEcCtD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	8.8e-05	0.00327	CbGpPWpGaD
Flucloxacillin—Dysgeusia—Epirubicin—prostate cancer	8.78e-05	0.000518	CcSEcCtD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	8.73e-05	0.00324	CbGpPWpGaD
Flucloxacillin—Feeling abnormal—Capecitabine—prostate cancer	8.66e-05	0.00051	CcSEcCtD
Flucloxacillin—Dizziness—Etoposide—prostate cancer	8.63e-05	0.000509	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—prostate cancer	8.61e-05	0.000508	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Capecitabine—prostate cancer	8.59e-05	0.000507	CcSEcCtD
Flucloxacillin—Body temperature increased—Docetaxel—prostate cancer	8.58e-05	0.000506	CcSEcCtD
Flucloxacillin—Abdominal pain—Docetaxel—prostate cancer	8.58e-05	0.000506	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Prednisone—prostate cancer	8.53e-05	0.000503	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	8.5e-05	0.00315	CbGpPWpGaD
Flucloxacillin—Urticaria—Capecitabine—prostate cancer	8.35e-05	0.000492	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Epirubicin—prostate cancer	8.32e-05	0.000491	CcSEcCtD
Flucloxacillin—Body temperature increased—Capecitabine—prostate cancer	8.3e-05	0.00049	CcSEcCtD
Flucloxacillin—Abdominal pain—Capecitabine—prostate cancer	8.3e-05	0.00049	CcSEcCtD
Flucloxacillin—Vomiting—Etoposide—prostate cancer	8.3e-05	0.00049	CcSEcCtD
Flucloxacillin—Anaemia—Epirubicin—prostate cancer	8.29e-05	0.000489	CcSEcCtD
Flucloxacillin—Dyspepsia—Prednisone—prostate cancer	8.24e-05	0.000486	CcSEcCtD
Flucloxacillin—Rash—Etoposide—prostate cancer	8.23e-05	0.000485	CcSEcCtD
Flucloxacillin—Dermatitis—Etoposide—prostate cancer	8.22e-05	0.000485	CcSEcCtD
Flucloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	8.19e-05	0.00304	CbGpPWpGaD
Flucloxacillin—Headache—Etoposide—prostate cancer	8.18e-05	0.000482	CcSEcCtD
Flucloxacillin—Decreased appetite—Prednisone—prostate cancer	8.13e-05	0.00048	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—prostate cancer	8.13e-05	0.000479	CcSEcCtD
Flucloxacillin—Malaise—Epirubicin—prostate cancer	8.09e-05	0.000477	CcSEcCtD
Flucloxacillin—Leukopenia—Epirubicin—prostate cancer	8.03e-05	0.000473	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	8.01e-05	0.00297	CbGpPWpGaD
Flucloxacillin—Constipation—Prednisone—prostate cancer	8e-05	0.000472	CcSEcCtD
Flucloxacillin—Hypersensitivity—Docetaxel—prostate cancer	7.99e-05	0.000471	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	7.92e-05	0.00294	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	7.82e-05	0.0029	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	7.81e-05	0.0029	CbGpPWpGaD
Flucloxacillin—Convulsion—Epirubicin—prostate cancer	7.77e-05	0.000458	CcSEcCtD
Flucloxacillin—Nausea—Etoposide—prostate cancer	7.76e-05	0.000457	CcSEcCtD
Flucloxacillin—Hypersensitivity—Capecitabine—prostate cancer	7.74e-05	0.000456	CcSEcCtD
Flucloxacillin—Feeling abnormal—Prednisone—prostate cancer	7.71e-05	0.000455	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—prostate cancer	7.7e-05	0.000454	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—prostate cancer	7.67e-05	0.000452	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Prednisone—prostate cancer	7.65e-05	0.000451	CcSEcCtD
Flucloxacillin—Arthralgia—Epirubicin—prostate cancer	7.63e-05	0.00045	CcSEcCtD
Flucloxacillin—Myalgia—Epirubicin—prostate cancer	7.63e-05	0.00045	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.58e-05	0.000447	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	7.55e-05	0.0028	CbGpPWpGaD
Flucloxacillin—Discomfort—Epirubicin—prostate cancer	7.54e-05	0.000445	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	7.51e-05	0.00278	CbGpPWpGaD
Flucloxacillin—Malaise—Doxorubicin—prostate cancer	7.48e-05	0.000441	CcSEcCtD
Flucloxacillin—Urticaria—Prednisone—prostate cancer	7.43e-05	0.000438	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—prostate cancer	7.43e-05	0.000438	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	7.43e-05	0.00276	CbGpPWpGaD
Flucloxacillin—Diarrhoea—Docetaxel—prostate cancer	7.42e-05	0.000438	CcSEcCtD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	7.41e-05	0.00275	CbGpPWpGaD
Flucloxacillin—Abdominal pain—Prednisone—prostate cancer	7.4e-05	0.000436	CcSEcCtD
Flucloxacillin—Body temperature increased—Prednisone—prostate cancer	7.4e-05	0.000436	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	7.32e-05	0.00272	CbGpPWpGaD
Flucloxacillin—Anaphylactic shock—Epirubicin—prostate cancer	7.32e-05	0.000432	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	7.24e-05	0.00268	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	7.23e-05	0.00268	CbGpPWpGaD
Flucloxacillin—Convulsion—Doxorubicin—prostate cancer	7.19e-05	0.000424	CcSEcCtD
Flucloxacillin—Diarrhoea—Capecitabine—prostate cancer	7.19e-05	0.000424	CcSEcCtD
Flucloxacillin—Nervous system disorder—Epirubicin—prostate cancer	7.18e-05	0.000423	CcSEcCtD
Flucloxacillin—Dizziness—Docetaxel—prostate cancer	7.18e-05	0.000423	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Epirubicin—prostate cancer	7.17e-05	0.000423	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	7.16e-05	0.00266	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	7.14e-05	0.00265	CbGpPWpGaD
Flucloxacillin—Skin disorder—Epirubicin—prostate cancer	7.11e-05	0.000419	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—prostate cancer	7.06e-05	0.000417	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—prostate cancer	7.06e-05	0.000417	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	7.06e-05	0.00262	CbGpPWpGaD
Flucloxacillin—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	7.04e-05	0.00261	CbGpPWpGaD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.02e-05	0.000414	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—prostate cancer	6.98e-05	0.000412	CcSEcCtD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	6.96e-05	0.00258	CbGpPWpGaD
Flucloxacillin—Dizziness—Capecitabine—prostate cancer	6.95e-05	0.00041	CcSEcCtD
Flucloxacillin—Vomiting—Docetaxel—prostate cancer	6.9e-05	0.000407	CcSEcCtD
Flucloxacillin—Hypersensitivity—Prednisone—prostate cancer	6.89e-05	0.000407	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	6.89e-05	0.00256	CbGpPWpGaD
Flucloxacillin—Rash—Docetaxel—prostate cancer	6.84e-05	0.000403	CcSEcCtD
Flucloxacillin—Dermatitis—Docetaxel—prostate cancer	6.84e-05	0.000403	CcSEcCtD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	6.81e-05	0.00253	CbGpPWpGaD
Flucloxacillin—Headache—Docetaxel—prostate cancer	6.8e-05	0.000401	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—prostate cancer	6.77e-05	0.000399	CcSEcCtD
Flucloxacillin—Vomiting—Capecitabine—prostate cancer	6.68e-05	0.000394	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.67e-05	0.000393	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—prostate cancer	6.64e-05	0.000392	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—prostate cancer	6.63e-05	0.000391	CcSEcCtD
Flucloxacillin—Rash—Capecitabine—prostate cancer	6.62e-05	0.000391	CcSEcCtD
Flucloxacillin—Dermatitis—Capecitabine—prostate cancer	6.62e-05	0.00039	CcSEcCtD
Flucloxacillin—Headache—Capecitabine—prostate cancer	6.58e-05	0.000388	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—prostate cancer	6.58e-05	0.000388	CcSEcCtD
Flucloxacillin—Nausea—Docetaxel—prostate cancer	6.45e-05	0.00038	CcSEcCtD
Flucloxacillin—Dyspepsia—Epirubicin—prostate cancer	6.44e-05	0.00038	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	6.42e-05	0.00238	CbGpPWpGaD
Flucloxacillin—Diarrhoea—Prednisone—prostate cancer	6.4e-05	0.000378	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	6.37e-05	0.00236	CbGpPWpGaD
Flucloxacillin—Decreased appetite—Epirubicin—prostate cancer	6.36e-05	0.000375	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Epirubicin—prostate cancer	6.32e-05	0.000373	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	6.28e-05	0.00233	CbGpPWpGaD
Flucloxacillin—Constipation—Epirubicin—prostate cancer	6.26e-05	0.000369	CcSEcCtD
Flucloxacillin—Nausea—Capecitabine—prostate cancer	6.24e-05	0.000368	CcSEcCtD
Flucloxacillin—Dizziness—Prednisone—prostate cancer	6.19e-05	0.000365	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.17e-05	0.000364	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA3—prostate cancer	6.15e-05	0.00228	CbGpPWpGaD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	6.08e-05	0.00226	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	6.07e-05	0.00225	CbGpPWpGaD
Flucloxacillin—Feeling abnormal—Epirubicin—prostate cancer	6.03e-05	0.000356	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Epirubicin—prostate cancer	5.98e-05	0.000353	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—prostate cancer	5.96e-05	0.000352	CcSEcCtD
Flucloxacillin—Vomiting—Prednisone—prostate cancer	5.95e-05	0.000351	CcSEcCtD
Flucloxacillin—Rash—Prednisone—prostate cancer	5.9e-05	0.000348	CcSEcCtD
Flucloxacillin—Dermatitis—Prednisone—prostate cancer	5.89e-05	0.000348	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—prostate cancer	5.89e-05	0.000347	CcSEcCtD
Flucloxacillin—Headache—Prednisone—prostate cancer	5.86e-05	0.000346	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.85e-05	0.000345	CcSEcCtD
Flucloxacillin—Urticaria—Epirubicin—prostate cancer	5.81e-05	0.000343	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	5.8e-05	0.00215	CbGpPWpGaD
Flucloxacillin—Constipation—Doxorubicin—prostate cancer	5.79e-05	0.000341	CcSEcCtD
Flucloxacillin—Abdominal pain—Epirubicin—prostate cancer	5.79e-05	0.000341	CcSEcCtD
Flucloxacillin—Body temperature increased—Epirubicin—prostate cancer	5.79e-05	0.000341	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	5.72e-05	0.00212	CbGpPWpGaD
Flucloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	5.69e-05	0.00211	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA4—prostate cancer	5.63e-05	0.00209	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	5.63e-05	0.00209	CbGpPWpGaD
Flucloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	5.61e-05	0.00208	CbGpPWpGaD
Flucloxacillin—Feeling abnormal—Doxorubicin—prostate cancer	5.58e-05	0.000329	CcSEcCtD
Flucloxacillin—Nausea—Prednisone—prostate cancer	5.56e-05	0.000328	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	5.55e-05	0.00206	CbGpPWpGaD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—prostate cancer	5.54e-05	0.000327	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	5.52e-05	0.00205	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA2—prostate cancer	5.48e-05	0.00203	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	5.42e-05	0.00201	CbGpPWpGaD
Flucloxacillin—Hypersensitivity—Epirubicin—prostate cancer	5.39e-05	0.000318	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—prostate cancer	5.38e-05	0.000317	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—prostate cancer	5.35e-05	0.000316	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—prostate cancer	5.35e-05	0.000316	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	5.34e-05	0.00198	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTA1—prostate cancer	5.29e-05	0.00196	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—NAT2—prostate cancer	5.23e-05	0.00194	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTO1—prostate cancer	5.23e-05	0.00194	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	5.16e-05	0.00191	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	5.16e-05	0.00191	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	5.02e-05	0.00186	CbGpPWpGaD
Flucloxacillin—Diarrhoea—Epirubicin—prostate cancer	5.01e-05	0.000295	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—prostate cancer	4.99e-05	0.000294	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	4.95e-05	0.00184	CbGpPWpGaD
Flucloxacillin—Dizziness—Epirubicin—prostate cancer	4.84e-05	0.000285	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	4.66e-05	0.00173	CbGpPWpGaD
Flucloxacillin—Vomiting—Epirubicin—prostate cancer	4.65e-05	0.000274	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—prostate cancer	4.63e-05	0.000273	CcSEcCtD
Flucloxacillin—Rash—Epirubicin—prostate cancer	4.61e-05	0.000272	CcSEcCtD
Flucloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	4.61e-05	0.00171	CbGpPWpGaD
Flucloxacillin—Dermatitis—Epirubicin—prostate cancer	4.61e-05	0.000272	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	4.6e-05	0.00171	CbGpPWpGaD
Flucloxacillin—Headache—Epirubicin—prostate cancer	4.59e-05	0.00027	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—prostate cancer	4.48e-05	0.000264	CcSEcCtD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	4.39e-05	0.00163	CbGpPWpGaD
Flucloxacillin—Nausea—Epirubicin—prostate cancer	4.35e-05	0.000256	CcSEcCtD
Flucloxacillin—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	4.34e-05	0.00161	CbGpPWpGaD
Flucloxacillin—Vomiting—Doxorubicin—prostate cancer	4.31e-05	0.000254	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—prostate cancer	4.27e-05	0.000252	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—prostate cancer	4.27e-05	0.000252	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—prostate cancer	4.24e-05	0.00025	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—HPGDS—prostate cancer	4.18e-05	0.00155	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	4.16e-05	0.00154	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	4.1e-05	0.00152	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTT1—prostate cancer	4.06e-05	0.00151	CbGpPWpGaD
Flucloxacillin—Nausea—Doxorubicin—prostate cancer	4.02e-05	0.000237	CcSEcCtD
Flucloxacillin—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	4.01e-05	0.00149	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	3.85e-05	0.00143	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	3.84e-05	0.00142	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	3.79e-05	0.00141	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—NCOA2—prostate cancer	3.66e-05	0.00136	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	3.41e-05	0.00127	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	3.36e-05	0.00125	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	3.23e-05	0.0012	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	3.19e-05	0.00118	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GGT1—prostate cancer	3.13e-05	0.00116	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—NCOA1—prostate cancer	3.08e-05	0.00114	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	3.04e-05	0.00113	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	3e-05	0.00111	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.93e-05	0.00109	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—COMT—prostate cancer	2.82e-05	0.00105	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.81e-05	0.00104	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.79e-05	0.00103	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.77e-05	0.00103	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.58e-05	0.000959	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.55e-05	0.000946	CbGpPWpGaD
Flucloxacillin—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.45e-05	0.000909	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HAO1—prostate cancer	2.42e-05	0.000897	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.42e-05	0.000896	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GRHL1—prostate cancer	1.97e-05	0.000731	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ADI1—prostate cancer	1.97e-05	0.000731	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CBR1—prostate cancer	1.97e-05	0.000731	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—TST—prostate cancer	1.97e-05	0.000731	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PSAT1—prostate cancer	1.97e-05	0.000731	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CSAD—prostate cancer	1.97e-05	0.000731	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GRHPR—prostate cancer	1.83e-05	0.00068	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CKMT2—prostate cancer	1.83e-05	0.00068	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.83e-05	0.00068	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.83e-05	0.00068	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PGAM2—prostate cancer	1.72e-05	0.000639	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NAGLU—prostate cancer	1.72e-05	0.000639	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTM3—prostate cancer	1.72e-05	0.000639	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—AOX1—prostate cancer	1.72e-05	0.000639	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.72e-05	0.000639	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—RFK—prostate cancer	1.72e-05	0.000639	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.72e-05	0.000639	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—AMACR—prostate cancer	1.63e-05	0.000606	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.63e-05	0.000606	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—DEGS1—prostate cancer	1.63e-05	0.000606	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NAT1—prostate cancer	1.63e-05	0.000606	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.63e-05	0.000606	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.56e-05	0.000578	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HPGD—prostate cancer	1.39e-05	0.000515	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.39e-05	0.000515	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.31e-05	0.000484	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.27e-05	0.000471	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—MTAP—prostate cancer	1.27e-05	0.000471	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.24e-05	0.000459	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.24e-05	0.000459	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ACSL4—prostate cancer	1.18e-05	0.000438	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.18e-05	0.000438	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ARG2—prostate cancer	1.13e-05	0.00042	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PHGDH—prostate cancer	1.13e-05	0.00042	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—UMPS—prostate cancer	1.13e-05	0.00042	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—LDHB—prostate cancer	1.11e-05	0.000412	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.09e-05	0.000404	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA3—prostate cancer	1.05e-05	0.00039	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—TCN2—prostate cancer	1.05e-05	0.00039	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—UCP3—prostate cancer	1.05e-05	0.00039	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PDHA1—prostate cancer	1.05e-05	0.00039	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HSD3B1—prostate cancer	1e-05	0.000372	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SLC22A3—prostate cancer	1e-05	0.000372	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.62e-06	0.000357	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA4—prostate cancer	9.62e-06	0.000357	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA2—prostate cancer	9.38e-06	0.000348	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SULT1A1—prostate cancer	9.26e-06	0.000344	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ABCG5—prostate cancer	9.26e-06	0.000344	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTA1—prostate cancer	9.05e-06	0.000336	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.95e-06	0.000332	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTO1—prostate cancer	8.95e-06	0.000332	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NAT2—prostate cancer	8.95e-06	0.000332	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PLCB2—prostate cancer	8.58e-06	0.000318	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—LRP2—prostate cancer	8.58e-06	0.000318	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.58e-06	0.000318	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—P4HB—prostate cancer	8.41e-06	0.000312	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SLC22A1—prostate cancer	8.18e-06	0.000304	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.97e-06	0.000296	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—MED12—prostate cancer	7.84e-06	0.000291	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GNG5—prostate cancer	7.78e-06	0.000289	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NCOA3—prostate cancer	7.5e-06	0.000278	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—HPGDS—prostate cancer	7.15e-06	0.000265	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.11e-06	0.000264	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ACHE—prostate cancer	6.94e-06	0.000257	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTT1—prostate cancer	6.94e-06	0.000257	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.86e-06	0.000254	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.67e-06	0.000248	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PRKACB—prostate cancer	6.64e-06	0.000246	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.57e-06	0.000244	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NCOA2—prostate cancer	6.26e-06	0.000232	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.97e-06	0.000221	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.83e-06	0.000216	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NQO1—prostate cancer	5.77e-06	0.000214	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—TH—prostate cancer	5.68e-06	0.000211	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.53e-06	0.000205	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GGT1—prostate cancer	5.35e-06	0.000199	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NCOA1—prostate cancer	5.27e-06	0.000196	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.2e-06	0.000193	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—RXRA—prostate cancer	5.02e-06	0.000186	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—COMT—prostate cancer	4.83e-06	0.000179	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTP1—prostate cancer	4.81e-06	0.000178	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ITPR1—prostate cancer	4.73e-06	0.000176	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—TYMS—prostate cancer	4.47e-06	0.000166	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—GSTM1—prostate cancer	4.42e-06	0.000164	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—LPL—prostate cancer	4.34e-06	0.000161	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.19e-06	0.000155	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—ERCC2—prostate cancer	4.15e-06	0.000154	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—MTHFR—prostate cancer	3.91e-06	0.000145	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PPARA—prostate cancer	3.83e-06	0.000142	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CAV1—prostate cancer	3.6e-06	0.000134	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.28e-06	0.000122	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—INS—prostate cancer	3.11e-06	0.000115	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—CREBBP—prostate cancer	3.04e-06	0.000113	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.88e-06	0.000107	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—NOS3—prostate cancer	2.72e-06	0.000101	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.51e-06	9.33e-05	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PTGS2—prostate cancer	2.49e-06	9.24e-05	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PTEN—prostate cancer	2.17e-06	8.06e-05	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—EP300—prostate cancer	2.07e-06	7.69e-05	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.53e-06	5.69e-05	CbGpPWpGaD
Flucloxacillin—CYP3A4—Metabolism—AKT1—prostate cancer	1.25e-06	4.65e-05	CbGpPWpGaD
